Abstract Morton's neuroma (MN) is a frequent cause of metatarsalgia. The aim of our study was to evaluate the efficacy of neuroma alcoholsclerosing therapy (NAST) under US guide in MN after a 10-month follow-up. Forty intermetatarsal neuromas underwent alcohol-sclerosing therapy after sonographic evaluation of their dimensions and echotexture. After subcutaneous anesthesia, a sclerosing solution composed of anesthetic (carbocaine-adrenaline 70%) and ethylic alcohol (30%) was injected inside the mass under US guidance. The procedure was repeated at intervals of 15 days until the resolution of the symptoms. A total or partial symptomatic relief was obtained in 36 cases (90%). No procedure-related complications were observed. Transitory plantar pain, due to the flogistic reaction induced by the sclerosing solution, occurred in 6 cases (15%). The 10-month follow-up revealed a 20-30% mass volume reduction and an adiposus-like change in echotexture. In the 4 cases (10%) of therapeutic failure, the preliminary sonography demonstrated a hypoechoic echotexture with a strong US beam attenuation corresponding to a highly fibrous neuroma after surgical resection. The NAST is a feasible and cost-efficient procedure with high rates of therapeutic success.
Introduction
Plantar interdigital neuroma, better known as MN, is a common disorder of the foot and is associated with forefoot pain and paresthesias caused by perineural fibrosis [1, 2] . This condition was first described by Civinini in 1835, Durlacher 1845 [3] , and subsequently by Morton in 1876 [4] .
The etiology is unknown. Many authors believe that an excessively pronated foot and cavus feet are usually implicated because of the increased tension on the plantar fascia and the intermetatarsal ligament [5, 6, 7, 8] .
The lesion consists of perineural fibrosis, local vascular proliferation, edema of the endoneurium, and axonal degeneration. Histologically, this condition is caused by fibrous degeneration of the soft tissues around the nerve, demyelination, and endoneurial fibrosis of the nerve [9, 10, 11, 12, 13, 14] .
The diagnosis may be made through the clinical history of pain radiating from the mid-foot to the toes on sonography and MRI [8, 9, 15, 16, 17] .
There exist various conservative and surgical methods of treatment for interdigital neuroma [18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28] .
Dockery [21] in 1999 tried a new therapeutic approach based on the injection of a 4% alcohol solution inside the lesion. Another group tested this possibility increasing the concentration of alcohol from 4 to 30% and reducing the number of injections. Moreover, this group was the first to engage a sonographic guide for the puncture of the neuroma [21, 22] .
The aim of this study was to evaluate NAST as a viable alternative to steroid injections or surgery in the treatment of MN associated with persistent symptoms.
Materials and methods
From January 1999 to June 2001, 40 consecutive patients (7 men and 33 women with a mean age of 48 years, range 28-65 years) with interdigital neuroma underwent NAST using a 30% alcoholsclerosing solution.
Patients with previous surgical therapy or other associated foot problems were excluded from the study.
All patients typically complained of pain and numbness in the affected interspace, exacerbated by tight-fitting footwear, and most complained of the sensation of a small plantar bump in the same site. All patients used orthotic devices before treatment without benefits. Twenty-two MNs involved the right foot, whereas 18 were located in the left foot. In all cases the neuroma was localized in the third interdigital space. The clinical diagnosis obtained through Mulder's maneuver was confirmed by US performed using 7.5-and 10-MHz linear-array transducers. Using a plantar and a dorsal approach, the patients were scanned in the transverse and longitudinal planes with regard to the metatarsal shafts. Thereafter, the longitudinal and transverse diameters of the neuroma were measured [14, 29] .
Informed consent was obtained in all patients prior to the procedure. Each patient was positioned supine with their knee flexed at 45°, with a hard pillow placed under the plantar surface of the foot in order to raise the metatarsophalangeal area.
Using a dorsal approach, a 26-G needle was positioned under sonographic guidance in the intermetatarsal space cranially to the head of the neuroma. After subcutaneous injection of 0.5-1 ml carbocaine 2% solution, the injection of 0.5 ml sclerosing solution composed of 70% carbocaine and 30% ethylic alcohol 95% was performed through a 22-G needle (Fig. 1) . The solution was slowly injected into the neuroma following the liquid flow inside the tissue. This procedure enables one to stop injecting whenever a leakage of the liquid is seen inside the plantar fat, which is perceived by the patient as a strong pain. At the end of treatment a US control scan was performed in order to exclude complications. Each subject underwent four injections at 15-day time intervals in order to avoid strong flogistic reactions.
Therapeutic success was established at the short-term followup (15 days) only on the basis of the remission of symptoms. The mass echotexture changes and the volume reduction were considered in the long-term follow up (10 months).
Follow-up
A clinical and sonographic follow-up was performed 10 months after the last injection. At the follow-up, patients were asked to grade the outcome of their treatment program using the system advocated by Johnson et al. (Table 1) [30]:
1. Completely satisfied (essentially pain free, no restrictions in activity, and only minor restriction in footwear) 2. Satisfied with minor reservations (occasional mild pain, minor restrictions in activity, and minor restrictions in footwear) 3. Satisfied with major reservation (mild or moderate pain, moderate restrictions in activity and major restrictions in footwear, but overall improvement) 4. Dissatisfied (no improvement in pain or worse pain, major restrictions in activity and footwear, no improvement or worse symptoms)
Sonographic follow-up was performed to evaluate the variations in shape, diameter, and echotexture of the neuromas.
To evaluate the effects of the procedure, a preliminary scale of sonographic appearance of the neuroma was made choosing as referential parameters the degree of echogenicity of the mass and the attenuation values of the sonographic beam determined by the mass.
Three different types of mass echotexture were found: type A, anechoic mass with low-beam attenuation; type B, hypoechoic mass with intermediate beam attenuation; type C, hypoechoic mass with high-beam attenuation (Fig. 2) .
Results
The preliminary US evaluation revealed a mass echotexture type A in 15 lesions, type B in 21 lesions, and type C in 4 lesions. The 4 patients with type-C echotexture neuroma underwent surgery (Fig. 2) .
A total of 160 injections were performed in 40 patients. Technical success was achieved in all cases (100%). The clinical evaluation of the 10-month long-term follow-up was performed according to Johnson et al.'s [30] scale: 21 patients were completely satisfied; 9 resulted satisfied with minor complications; 6 were satisfied with major complications; and 4 patients were dissatisfied and underwent surgery.
Two of the 17 patients with a partial relief of symptoms at the short-term follow-up referred complete satisfaction after 10 months.
The long-term US evaluation considered the changes in mass echotexture and volume (visual evaluation; Fig. 3 ). All the masses presented an increase in echotexture, with no volume reduction in 15 cases (Fig. 3A) and with volume reduction in 21 cases (Fig. 3B) . The echotextural classification of neuromas is carried out only in the preprocedural phase to obtain a prognostic factor of the procedural success. This evaluation is not applicable after alcoholization.
Mass volume reduction was considered as a reduction of at least 20% in the longitudinal or transverse diameter. All the 21 patients with a positive Johnson et al. [30] scale for complete satisfaction presented a mass volume reduction.
Discussion
Morton's neuroma is as Morton described it in 1876: "a particular and painful affection of the fourth metatarsophalangeal articulation". This disease is one of the most common disorders of the foot [2] . The differential diagnosis of MN must be made with stress fracture, tendon sheath ganglion, foreign body reaction, nerve sheath tumor, dislocation of the metatarsophalangeal joint and intermetatarsal bursitis [15] . Diagnosis of MN is usually made through an accurate anamnesis and physical examination and must be confirmed by US [9] .
Sonography is considered as an accurate means of revealing MN. Several studies identified 95-98% of MNs prospectively and up to 100% retrospectively [9] . Neuromas have a US appearance of a hypoechoic mass, with regard to the muscle. Many studies emphasize the importance of US imaging in the establishment of the presence of multiple neuromas, the exact dimensions, and localization [9, 16, 17 ]. Shapiro and Shapiro described hypoechoic areas within some neuromas and proposed that these were correlated to the adipous envelopment of the mass [17] . Some authors advocate MRI with good results in terms of sensitivity and specificity [15] . Although the cause remains uncertain, in most cases a treatment is mandatory due to limitations in the patient's activities.
The injection of corticosteroids associated to an anesthetic into the affected interspace is a widely acknowledged technique. More recently, the decompres-516 A moderate pain in the site of the anesthesia was referred after 23 injections disappearing after 3-4 days in all cases.
A transitory plantar pain due to a subtle leakage of fluid was referred after 12 injections. No major procedure-related complications occurred.
At the short-term 15 days follow-up from the last injection a partial (17 patients; 42.5%) or total (19 patients; 47.5%) relief of sensory disturbances and pain was observed in 36 cases (90%). Four cases (10%) where no symptomatic improvement was obtained had to undergo neurectomy and were considered failures of NAST. [31] .
Sclerosing therapy is a new choice for the treatment of MN. Ethylic alcohol has a great affinity to the nervous tissue and when injected in proximity to the nerve is able to induce dehydration, necrosis, and precipitation of the cell protoplasm resulting in a neuritis with a wallerian nerve degeneration (chemical neurolysis) [16, 21, 22, 32] . Alcohol inhibits neurotransmitter receptor function, an ATP-gated ion channel interacting with a small hydrophobic pocket on the receptor protein. A 30% (approximately 100 mM) ethanol solution is employed since the range of concentrations producing a nervous signal inhibition is 80-120 mM (higher than 20%) [21, 33] .
The role of US in MN is not merely restricted to a guiding function. In fact, the evaluation of sonographic characteristics may have a predictive value for the procedural success. As suggested by the sonographic evaluation of the four lesions undergoing surgery, a type-C echotexture is a negative prognostic factor for the procedural success. In our opinion, this type of echotexture does not allow an optimal alcoholization, although 4 cases are not enough to postulate significant conclusions.
The long-term US evaluation demonstrates how the echotextural change is a significant parameter for the clinical success, whereas mass volume reduction is significant only in terms of an objective grading of the symptomatologic relief. Johnson et al.'s [30] scale, on the other hand, is suitable for the assessment of clinical improvement, although it is a subjective method of evaluation.
Patients undergoing alcohol-sclerosing therapy may be discharged immediately after therapy and can continue their normal daily activities. The pain that may occur Long-term results indicate high rates of clinical success, comparable or greater than those related to other surgical procedure. The role of NAST should be further analyzed in subjects with multiple neuromas and in those cases of surgical failure, after neurectomy, where a new intervention is difficult to propose.
